Remimazolam Besylate in Mechanically Ventilated ICU Patients
Not yet recruiting
Wuhan Union Hospital, China
Phase 3
2021-03-01
The purpose of this study is to evaluate the efficacy and safety of remimazolam compared to
propofol for sedation in mechanically ventilated ICU patients.
A Comparative Study of Rimazolam and Propofol Combined With Etomidate in Gastroenteroscopy in Elderly Patients
Not yet recruiting
Peking University People's Hospital
N/A
2021-11-01
Studies have shown that etomidate combined with propofol in gastroscopy has high safety and
lower incidence of hypoxia and hypotension, suggesting the advantages of etomidate combined
with propofol in elderly patients.
Remimazolam Besylate is a 1.1 class new drug that acts on GABA receptors and is metabolized
by plasma esterase with fast metabolism time, only 1/7 of midazolam, which may be more
suitable for elderly patients. Therefore, this study intends to explore the safety and
effectiveness of two sedation schemes in gastroenteroscopy for elderly patients.
Comparison of Remimazolam With Flumazenil vs. Propofol During RFCA for Atrial Fibrillation
Not yet recruiting
Seoul National University Hospital
N/A
2022-05-30
This prospective randomized trial aims to compare recovery time from discontinuation of
remimazolam followed by flumazenil administration vs. propofol total intravenous anesthesia
as the main general anesthetics during radiofrequency catheter ablation treatment of atrial
fibrillation.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
